imipramine has been researched along with Encephalitis Lethargica Type Parkinsonism in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| GILLINGHAM, FJ | 1 |
| SMYTHIES, JR | 1 |
| Schneider, LS | 1 |
| Chui, HC | 1 |
| Severson, JA | 1 |
| Sloane, RB | 1 |
2 other studies available for imipramine and Encephalitis Lethargica Type Parkinsonism
| Article | Year |
|---|---|
A CASE OF POSTENCEPHALITIC PARKINSONISM RESPONDING TO COMBINED SURGICAL AND MEDICINAL TREATMENT.
Topics: Amitriptyline; Chlordiazepoxide; Depression; Depressive Disorder; Drug Therapy; Encephalitis; Eye Mo | 1965 |
Decreased platelet 3H-imipramine binding in Parkinson's disease.
Topics: Aged; Blood Platelets; Carrier Proteins; Depressive Disorder; Female; Humans; Imipramine; Male; Park | 1988 |